Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
API Holdings is an Indian digital healthcare company that operates an integrated, technology-enabled platform spanning online pharmacy, diagnostics, clinic software, hospital procurement, and pharmaceutical supply-chain services. The company is best known as the parent of PharmEasy and also owns or operates brands including Thyrocare, Retailio, Docon, and Aknamed. Rather than developing therapeutic drugs, API Holdings focuses on healthcare access, fulfillment, diagnostics, and software infrastructure across the healthcare value chain. Its business model serves consumers as well as pharmacies, hospitals, doctors, clinics, diagnostic labs, wholesalers, and pharmaceutical manufacturers. The company appears to be a commercial-stage healthtech platform rather than a biotech or pharma product developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apis Holdings.